Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
- 1 April 2005
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 97 (1), 26-34
- https://doi.org/10.1016/j.ygyno.2004.11.051
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Cleavage of 14-3-3 Protein by Caspase-3 Facilitates Bad Interaction with Bcl-x(L) during ApoptosisJournal of Biological Chemistry, 2003
- The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to MitochondriaPublished by Elsevier BV ,2002
- Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein ComplexJournal of Biological Chemistry, 2001
- Frequent Loss of PTEN Expression Is Linked to Elevated Phosphorylated Akt Levels, but Not Associated with p27 and Cyclin D1 Expression, in Primary Epithelial Ovarian CarcinomasThe American Journal of Pathology, 2001
- Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis ProteinsEndocrinology, 2001
- Bax-induced Caspase Activation and Apoptosis via Cytochromec Release from Mitochondria Is Inhibitable by Bcl-xLJournal of Biological Chemistry, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- Mutation of thePTENTumor Suppressor Gene Is Not a Feature of Ovarian CancersGynecologic Oncology, 1998
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.JCI Insight, 1991